Connect with us
The device developed by Nexkin Medical enables skin prick test reading with the help of state-of-the-art technology, streamlining clinical procedures, and integrating digital workflows. The company,...
Pharma Mar's investment in research and development (R&D) rose by 19.6% to $17.7 million (€14.7 million). Other operating expenses fell by 13% to $15.5 million (€12.9...
Grifols' gross operating profit (Ebitda) was $356.4 million (€296.8 million) compared to $421 million (€351 million) in the first quarter of 2020 and accounted for 25.1%...
Dedalus closes the acquisition of DXC Technology's healthcare software business. The company, which specializes in digital health and diagnostics, intends to expand its business in major...
The cost of products sold by Sanofi was $3.25 billion (€2.68 billion) in the first quarter of 2021, down 6.3%. Selling and general expenses also fell...
A well-managed European ETF could include biotechnology companies traded on one of the European exchanges as well as European-headquartered companies listed on U.S. exchanges. Stocks should...
Globally, Dräger posted a 22.5% rise in turnover in 2020 compared with the previous year to $4.1 billion (€3.4 billion). The medical technology segment saw an...
Making Genetics advances in genetics and epigenetics. The Spanish biotech company seeks $3.6 million (€3 million) to conduct a clinical trial in Europe. Making Genetics specializes...
The company says the operating context of the self-care industry is different from that of the prescription drug industry. Sanofi, which will continue to own its...
Noventure is a Spanish company based in Barcelona. It specializes in licensing innovative medical devices based on specialized food substances and supplements. Ulkox/Oleoabrax are Noventure's first...
 |
|
 |  |
 |
|